Lifeboat Foundation

While is seems like the majority of the longevity space is currently overly captivated by the Aubrey de Grey/SENS debacle, the U.S. National Academy of Sciences, Healthy Longevity Global Innovator Summit is now beginning — Most interestingly, former R&D Head at PepsiCo, Dr. Mehmoud Khan, will be speaking in his new role as CEO of the Hevolution Foundation; a potential multi-billion $$$ initiative with a longevity angle — Everyone should keep their eye on this one…

The National Academy of Medicine (NAM) will hold its inaugural Healthy Longevity Global Innovator Summit in September 2,021 with support from Johnson and Johnson Innovation and The John A. Hartford Foundation. The event will be virtual and held over three days, September 13 14, and 22 and feature an immersive, interactive digital venue with unique opportunities to engage and connect.

The Innovator Summit will honor the 154 international Healthy Longevity Catalyst Awardees from 2020 and bring together industry leaders, academics, researchers, scientists, and entrepreneurs whose work contributes to the field of healthy longevity. Attendees will learn about the early-stage, award-winning innovations, hear from leaders in the field of healthy longevity, and take advantage of various opportunities to interact directly with other attendees, with a view to fostering interdisciplinary and cross-sector collaboration.

Continue reading “Healthy Longevity Global Innovator Summit” »

As we age, our bones become thinner, we suffer fractures more often, and bone-diseases such as osteoporosis are more likely to occur. One responsible mechanism involves the impaired function of the bone-marrow stem cells, which are required for the maintenance of bone integrity. Researchers from the Max Planck Institute for Biology of Ageing and CECAD Cluster of Excellence for Ageing Research at the University of Cologne have now shown that the reduced stem cell function upon aging is due to changes in their epigenome. They were able to reverse these changes in isolated stem cells by adding acetate. This fountain of youth for the epigenome could become important for the treatment of diseases such as osteoporosis.

Aging Researchers have been looking at epigenetics as a cause of aging processes for some time. Epigenetics looks at changes in genetic information and chromosomes that do not alter the sequence of the genes themselves, but do affect their activity. One possibility is changes in proteins called histones, which package the DNA in our cells and thus control access to DNA. The Cologne research group of Peter Tessarz has now studied the epigenome of mesenchymal stem cells. These stem cells are found in bone marrow and can give rise to different types of cells such as cartilage, bone and fat cells.

With all that said, it’s natural for humans to crave and eat limited amounts of sugar. After going through all the research, here’s what I am doing for myself.

For example, foods high in fructose stimulate ghrelin while suppressing leptin—hormones responsible for hunger and satiety. Sugar can promote chronic hyperglycemia, which can both lead to weight gain and is another risk for diabetes. And sugary drinks, especially, are tied directly to obesity.

Sugar and aging: a bad combination (so what should we do?)

Continue reading “Sugar and Aging: What You Need to Know” »

This is an emerging therapeutic technique that works by targeting the underlying causes of a disease, rather than the symptoms it causes. It does this by targeting a particular gene, and preventing it from making the protein that it produces.

The United Kingdom’s NHS has very recently approved a new cholesterol-lowering jab which will be offered to 300,000 people over the next three years.

The drug – inclisiran – will be administered twice a year as an injection.

Continue reading “A Clever ‘Gene Silencing’ Injection Has Been Approved For Treating High Cholesterol” »

Physicists at The Australian National University (ANU) have developed extremely powerful microscopic lasers that are even smaller than the wavelength of the light they produce. So called ‘nanolasers’ have a huge variety of medical, surgical, industrial and military uses, covering everything from hair removal to laser printers and night-time surveillance. According to lead researcher Professor Yuri Kivshar, the nanolasers developed by his team promise to be even more powerful than existing lasers, allowing them to be useful in smaller-scale devices. “They can also be integrated on a chip,” he said.

California-based startup Relativity Space is manufacturing rockets using giant Westworld-esque 3D printers, a process they say could drastically shorten the rocket-making process from years to weeks. Tim Ellis, the company’s 30-year-old CEO, explains how the high degree of automation in Relativity’s factory has enabled them to build rockets remotely during the Covid-19 pandemic.

#Coronavirus #Space #HelloWorld.
——-
Like this video? Subscribe to Bloomberg on YouTube: https://www.youtube.com/Bloomberg?sub_confirmation=1
Become a Quicktake Member for exclusive perks: https://www.youtube.com/bloomberg/join.

Continue reading “The SpaceX Competitor is Printing Its Rockets” »

Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting.

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain Drs Clemente-Moragón and Martínez-Milla contributed equally to this work.

“The agency continues to monitor the rise of COVID cases in the Kennedy area, which combined with other factors such as weather and first-time operations, is impacting our schedule of operations,” NASA spokesperson Kathryn Hambleton told Ars. “Moving step by step, we are progressing toward launch while keeping our team as safe as possible.”

However, the SLS has already been delayed for years and surpassed budget expectations by billions of dollars. So while the pandemic has certainly thrown another wrench into the works, it’s not like things were progressing smoothly before the coronavirus struck. Regardless, Hambleton says that NASA should offer a revised schedule soon.

“As always, we will fly only when we are ready,” she told Ars Technica.

“The dream of predicting a protein shape just from its gene sequence is now a reality,” said Paul Adams, Associate Laboratory Director for Biosciences at Berkeley Lab. For Adams and other structural biologists who study proteins, predicting their shape offers a key to understanding their function and accelerating treatments for diseases like cancer and COVID-19.

The current approaches to accurately mapping that shape, however, usually rely on complex experiments at synchrotrons. But even these sophisticated processes have their limitations—the data and quality aren’t always sufficient to understand a protein at an atomic level. By applying powerful machine learning methods to the large library of protein structures it is now possible to predict a protein’s shape from its gene sequence.

Researchers in Berkeley Lab’s Molecular Biophysics & Integrated Bioimaging Division joined an international effort led by the University of Washington to produce a computer software tool called RoseTTAFold. The algorithm simultaneously takes into account patterns, distances, and coordinates of amino acids. As these data inputs flow in, the tool assesses relationships within and between structures, eventually helping to build a very detailed picture of a protein’s shape.